Current Drug Targets - CNS & Neurological Disorders
Title: Editorial [Hot Topic: Cognition Therapeutics (Guest Editor: Miao-Kun Sun)]
Volume: 4 Issue: 5
Author(s): Miao-Kun Sun
Affiliation:
Export Options
About this article
Cite this article as:
Sun Miao-Kun, Editorial [Hot Topic: Cognition Therapeutics (Guest Editor: Miao-Kun Sun)], Current Drug Targets - CNS & Neurological Disorders 2005; 4 (5) . https://dx.doi.org/10.2174/156800705774322094
DOI https://dx.doi.org/10.2174/156800705774322094 |
Print ISSN 1568-007X |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-007X |
22
Related Articles
-
On the Possible Relevance of Bottom-up Pathways in the Pathogenesis of Alzheimer’s Disease
Current Topics in Medicinal Chemistry Global Cerebral Ischemia: Synaptic and Cognitive Dysfunction
Current Drug Targets Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Containing Dipeptide-Dominant Pharmaconutrition Provision
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Anti-VEGF Molecules for the Management of Diabetic Macular Edema
Current Pharmaceutical Design CCL2-CCR2 Signaling in Disease Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets Menopausal Transition and Chronic Diseases
Current Women`s Health Reviews Altered Calmodulin Degradation and Signaling in Non-Neuronal Cells from Alzheimer’s Disease Patients
Current Alzheimer Research Evaluation of Pharmacological Treatment Strategies in Traumatic Brain Injury
Current Pharmaceutical Design Neuropharmacological Actions of Metformin in Stroke
Current Neuropharmacology State-of-the-Art Methodologies for the Discovery and Characterization of DNA G-Quadruplex Binders
Current Pharmaceutical Design Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease
Current Stem Cell Research & Therapy Do Geriatric Outpatients Adhere to Medication Changes Advised After Assessment? An Exploratory Pilot Study
Current Clinical Pharmacology Acid Sensing Ion Channels and Acid Nociception
Current Pharmaceutical Design Auditory Event-related Potentials in Mild Cognitive Impairment and Alzheimer’s Disease
Current Alzheimer Research Binding of the PET Radiotracer [<sup>18</sup>F]BF227 Does not Reflect the Presence of Alpha-Synuclein Aggregates in Transgenic Mice
Current Alzheimer Research Transition of Care for Patients with Diabetes
Current Diabetes Reviews Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss
Current Neurovascular Research New Developments in Anti-Platelet Therapies Potential Use of CD39/Vascular ATP Diphosphohydrolase in Thrombotic Disorders
Current Drug Targets A Brief Overview of Tyrosine Hydroxylase and α-Synuclein in the Parkinsonian Brain
CNS & Neurological Disorders - Drug Targets Genomics and the Prospects of Existing and Emerging Therapeutics for Cardiovascular Diseases
Current Pharmaceutical Design